相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Adjuvant Selection for Influenza and RSV Prefusion Subunit Vaccines
Ariel Isaacs et al.
VACCINES (2021)
COVID-19 vaccines: rapid development, implications, challenges and future prospects
Shivaji Kashte et al.
HUMAN CELL (2021)
IABS/CEPI platform technology webinar: Is it possible to reduce the vaccine development time?
Joris Vandeputte et al.
BIOLOGICALS (2021)
Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trial
Keith J. Chappell et al.
LANCET INFECTIOUS DISEASES (2021)
SARS-CoV-2: Insight in genome structure, pathogenesis and viral receptor binding analysis-An updated review
Eijaz Ahmed Bhat et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2021)
Viral targets for vaccines against COVID-19
Lianpan Dai et al.
NATURE REVIEWS IMMUNOLOGY (2021)
Developing vaccines against epidemic-prone emerging infectious diseases
Valentina Bernasconi et al.
BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ (2020)
Emerging coronaviruses: Genome structure, replication, and pathogenesis
Yu Chen et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Characterization of novel monoclonal antibodies against MERS-coronavirus spike protein
Junghyun Goo et al.
VIRUS RESEARCH (2020)
Immunogenicity of a DNA vaccine candidate for COVID-19
Trevor R. F. Smith et al.
NATURE COMMUNICATIONS (2020)
Middle East respiratory syndrome
Ziad A. Memish et al.
LANCET (2020)
Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open -label, phase 1 trial
Till Koch et al.
LANCET INFECTIOUS DISEASES (2020)
A single dose of ChAdOx1 MERS provides protective immunity in rhesus macaques
Neeltje van Doremalen et al.
SCIENCE ADVANCES (2020)
Coronavirus vaccine development: from SARS and MERS to COVID-19
Yen-Der Li et al.
JOURNAL OF BIOMEDICAL SCIENCE (2020)
Preclinical Studies of Immunogenity, Protectivity, and Safety of the Combined Vector Vaccine for Prevention of the Middle East Respiratory Syndrome
I. Dolzhikova et al.
ACTA NATURAE (2020)
Human coronaviruses OC43 and HKU1 bind to 9-O-acetylated sialic acids via a conserved receptor-binding site in spike protein domain A
Ruben J. G. Hulswit et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial
Kayvon Modjarrad et al.
LANCET INFECTIOUS DISEASES (2019)
Recent Advances in the Vaccine Development Against Middle East Respiratory Syndrome-Coronavirus
Chean Yeah Yong et al.
FRONTIERS IN MICROBIOLOGY (2019)
CEPI: Driving Progress Towards Epidemic Preparedness And Response
Dimitrios Gouglas et al.
EPIDEMIOLOGIC REVIEWS (2019)
Humoral Immunogenicity and Efficacy of a Single Dose of ChAdOx1 MERS Vaccine Candidate in Dromedary Camels
Naif Khalaf Alharbi et al.
SCIENTIFIC REPORTS (2019)
Middle East Respiratory Syndrome Vaccine Candidates: Cautious Optimism
Craig Schindewolf et al.
VIRUSES-BASEL (2019)
A recombinant VSV-vectored MERS-CoV vaccine induces neutralizing antibody and T cell responses in rhesus monkeys after single dose immunization
Renqiang Liu et al.
ANTIVIRAL RESEARCH (2018)
Distribution and absence of generalized lesions in mice following single dose intramuscular inoculation of the vaccine candidate MVA-MERS-S
Martin C. Langenmayer et al.
BIOLOGICALS (2018)
Development of a Broadly Accessible Venezuelan Equine Encephalitis Virus Replicon Particle Vaccine Platform
Sudhakar Agnihothram et al.
JOURNAL OF VIROLOGY (2018)
Heterologous prime-boost vaccination with adenoviral vector and protein nanoparticles induces both Th1 and Th2 responses against Middle East respiratory syndrome coronavirus
Seo-Yeon Jung et al.
VACCINE (2018)
Funding vaccines for emerging infectious diseases
Gary Wong et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)
Enhanced protection in mice induced by immunization with inactivated whole viruses compare to spike protein of middle east respiratory syndrome coronavirus
Yao Deng et al.
EMERGING MICROBES & INFECTIONS (2018)
The WHO R&D Blueprint: 2018 review of emerging infectious diseases requiring urgent research and development efforts
Massinissa Si Mehand et al.
ANTIVIRAL RESEARCH (2018)
New Vaccine Technologies to Combat Outbreak Situations
Susanne Rauch et al.
FRONTIERS IN IMMUNOLOGY (2018)
The cost and challenge of vaccine development for emerging and emergent infectious diseases
Joel N. Maslow
LANCET GLOBAL HEALTH (2018)
Dromedary Camels and the Transmission of Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
M. G. Hemida et al.
TRANSBOUNDARY AND EMERGING DISEASES (2017)
One-Health: a Safe, Efficient, Dual-Use Vaccine for Humans and Animals against Middle East Respiratory Syndrome Coronavirus and Rabies Virus
Christoph Wirblich et al.
JOURNAL OF VIROLOGY (2017)
New Vaccines against Epidemic Infectious Diseases
John-Arne Rottingen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Tectonic conformational changes of a coronavirus spike glycoprotein promote membrane fusion
Alexandra C. Walls et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen
Jesper Pallesen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice
Naif Khalaf Alharbi et al.
VACCINE (2017)
The recombinant N-terminal domain of spike proteins is a potential vaccine against Middle East respiratory syndrome coronavirus (MERS-CoV) infection
Lan Jiaming et al.
VACCINE (2017)
MERS-CoV spike nanoparticles protect mice from MERS-CoV infection
Christopher M. Coleman et al.
VACCINE (2017)
Immunogenicity of Candidate MERS-CoV DNA Vaccines Based on the Spike Protein
Sawsan S. Al-amri et al.
SCIENTIFIC REPORTS (2017)
Vaccines for epidemic infections and the role of CEPI
Stanley A. Plotkin
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
Newcastle disease virus-based MERS-CoV candidate vaccine elicits high-level and lasting neutralizing antibodies in Bactrian camels
Liu Ren-qiang et al.
JOURNAL OF INTEGRATIVE AGRICULTURE (2017)
Protective efficacy of a novel simian adenovirus vaccine against lethal MERS-CoV challenge in a transgenic human DPP4 mouse model
Vincent J. Munster et al.
NPJ VACCINES (2017)
An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels
Bart L. Haagmans et al.
SCIENCE (2016)
MERS-CoV outbreak following a single patient exposure in an emergency room in South Korea: an epidemiological outbreak study
Sun Young Cho et al.
LANCET (2016)
MERS-CoV vaccine candidates in development: The current landscape
Kayvon Modjarrad
VACCINE (2016)
A recombinant receptor-binding domain of MERS-CoV in trimeric form protects human dipeptidyl peptidase 4 (hDPP4) transgenic mice from MERS-CoV infection
Wanbo Tai et al.
VIROLOGY (2016)
Middle East Respiratory Syndrome Coronavirus (MERS-CoV) origin and animal reservoir
Hamzah A. Mohd et al.
VIROLOGY JOURNAL (2016)
Immunization with inactivated Middle East Respiratory Syndrome coronavirus vaccine leads to lung immunopathology on challenge with live virus
Anurodh Shankar Agrawal et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)
Systemic and mucosal immunity in mice elicited by a single immunization with human adenovirus type 5 or 41 vector-based vaccines carrying the spike protein of Middle East respiratory syndrome coronavirus
Xiaojuan Guo et al.
IMMUNOLOGY (2015)
A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform
Anna H. Malczyk et al.
JOURNAL OF VIROLOGY (2015)
Protective Efficacy of Recombinant Modified Vaccinia Virus Ankara Delivering Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein
Asisa Volz et al.
JOURNAL OF VIROLOGY (2015)
Middle East respiratory syndrome
Alimuddin Zumla et al.
LANCET (2015)
A synthetic consensus anti-spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates
Karuppiah Muthumani et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Live attenuated vaccines: Historical successes and current challenges
Philip D. Minor
VIROLOGY (2015)
Structural basis for the neutralization of MERS-CoV by a human monoclonal antibody MERS-27
Xiaojuan Yu et al.
SCIENTIFIC REPORTS (2015)
Bat Origins of MERS-CoV Supported by Bat Coronavirus HKU4 Usage of Human Receptor CD26
Qihui Wang et al.
CELL HOST & MICROBE (2014)
Structure and immune recognition of trimeric pre-fusion HIV-1 Env
Marie Pancera et al.
NATURE (2014)
Immunization with vesicular stomatitis virus vaccine expressing the Ebola glycoprotein provides sustained long-term protection in rodents
Gary Wong et al.
VACCINE (2014)
Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice
Christopher M. Coleman et al.
VACCINE (2014)
Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4
Nianshuang Wang et al.
CELL RESEARCH (2013)
Middle East Respiratory Syndrome Coronavirus Spike Protein Delivered by Modified Vaccinia Virus Ankara Efficiently Induces Virus-Neutralizing Antibodies
Fei Song et al.
JOURNAL OF VIROLOGY (2013)
Identification of a Receptor-Binding Domain in the S Protein of the Novel Human Coronavirus Middle East Respiratory Syndrome Coronavirus as an Essential Target for Vaccine Development
Lanying Du et al.
JOURNAL OF VIROLOGY (2013)
Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Announcement of the Coronavirus Study Group
Raoul J. de Groot et al.
JOURNAL OF VIROLOGY (2013)
A decade after SARS: strategies for controlling emerging coronaviruses
Rachel L. Graham et al.
NATURE REVIEWS MICROBIOLOGY (2013)
Efficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine
Scott M. Hammer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus
Jason S. McLellan et al.
SCIENCE (2013)
Engineering a Replication-Competent, Propagation-Defective Middle East Respiratory Syndrome Coronavirus as a Vaccine Candidate
Fernando Almazan et al.
MBIO (2013)
Relevance of a pre-existing measles immunity prior immunization with a recombinant measles virus vector
Marlyse C. Knuchel et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus
Chien-Te Tseng et al.
PLOS ONE (2012)
Genomic Characterization of a Newly Discovered Coronavirus Associated with Acute Respiratory Distress Syndrome in Humans
Sander van Boheemen et al.
MBIO (2012)
Electroporation delivery of DNA vaccines: prospects for success
Niranjan Y. Sardesai et al.
CURRENT OPINION IN IMMUNOLOGY (2011)
Viral vectors as vaccine platforms: deployment in sight
Christine S. Rollier et al.
CURRENT OPINION IN IMMUNOLOGY (2011)
DNA vaccines: an historical perspective and view to the future
Margaret A. Liu
IMMUNOLOGICAL REVIEWS (2011)
A Double-Inactivated Severe Acute Respiratory Syndrome Coronavirus Vaccine Provides Incomplete Protection in Mice and Induces Increased Eosinophilic Proinflammatory Pulmonary Response
Meagan Bolles et al.
JOURNAL OF VIROLOGY (2011)
International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: Correlates of high Ad5 titers and implications for potential HIV vaccine trials
T. Christopher Mast et al.
VACCINE (2010)
Vaccines to prevent severe acute respiratory syndrome coronavirus-induced disease
Luis Enjuanes et al.
VIRUS RESEARCH (2008)
Biodistribution of DNA plasmid vaccines against HIV-1, Ebola, severe acute respiratory syndrome, or West Nile virus is similar, without integration, despite differing plasmid backbones or gene inserts
RL Sheets et al.
TOXICOLOGICAL SCIENCES (2006)
Chimeric adenovirus vector encoding reovirus attachment protein σ1 targets cells expressing junctional adhesion molecule 1
GT Mercier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Safety of modified vaccinia virus Ankara (MVA) in immune-suppressed macaques
KJ Stittelaar et al.
VACCINE (2001)
Design and production of recombinant subunit vaccines
M Hansson et al.
BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY (2000)
分享论文
